BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, May 9, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 1, 2000
View Archived Issues
Connetics achieves significant growth in 1999
Read More
Cell Pathways signs commercialization agreement for Aptosyn
Read More
Novel compounds to treat thyroid disorders in development at Lotus
Read More
Alcon makes milestone payment to Pharmacyclics for Optrin
Read More
PEG-rHuMGDF tested as adjunct to chemotherapy in AML
Read More
Antisense oligonucleotides targeting TNFR1 expression designed at Isis
Read More
Discovery commences pivotal phase III trial of Surfaxin in infants with MAS
Read More
Techniclone licenses novel antiangiogenic antibody
Read More
Progress during 1999 highlighted by Sepracor
Read More
FDA advisory committee recommends approval of Novantrone for MS indication
Read More
Trimeris and Roche advance HIV fusion inhibitors in clinical testing
Read More
New series from Lilly affecting serotonergic pathways
Read More
Subunit-selective GABA-A receptor ligands as safe and effective agents for anxiety
Read More
Beta-amyloid peptide inhibitors designed as part of Elan-Lilly collaboration
Read More
Roche devotes resources to study of orphan opioid receptor ligands
Read More
New radioligands for visualizing DAT in the human brain
Read More
Ono discloses N-type calcium channel blockers and their use
Read More
New Zeria compounds with alpha1-adrenoceptor-blocking effects
Read More
Hydroxamic acid-based MMP inhibitors in the DuPont pipeline
Read More
Kosan develops efficient production system for potent anticancer drugs
Read More
New patents cover significant improvements to Avigen's AAV vector technology
Read More
Cytoclonal reports design and development of new agents for rhinovirus and other viral infections
Read More
Merck reports success with early study of HIV-1 integrase inhibitors
Read More
EntreMed to commence phase I trial of Angiostatin protein
Read More
New oral IBD treatment targets macrophages and microfold cells
Read More
Patients prefer Invicorp over Caverject
Read More
